An investigation of the cytotoxicity and histocompatibility of in situ forming lactic acid based orthopedic biomaterials

Journal of Biomedical Materials Research

Volumn 63, Issue 5, 2002, Pages 484-491

  Burdick, Jason A ^a   Padera, Robert F ^b,c   Huang, Janice V ^a   Anseth, Kristi S ^d  

^a UCB 450   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

Biocompatibility; Bone tissue engineering; In situ formation; Orthopedic biomaterials; Photopolymerization

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADATION; BONE; IMPLANTS (SURGICAL); OLIGOMERS; POLYMERS; TISSUE;

CYTOTOXICITY;

ORTHOPEDICS;

ALKALINE PHOSPHATASE; BIOMATERIAL; LACTIC ACID; OLIGOMER; POLYMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CALVARIA; CELL ACTIVITY; CELL CULTURE; CELL FUNCTION; CHEMICAL COMPOSITION; CYTOTOXICITY; CYTOTOXICITY TEST; HISTOCOMPATIBILITY; INFLAMMATION; MATERIALS TESTING; NONHUMAN; ORTHOPEDIC SURGERY; OSTEOBLAST; RAT;

ALKALINE PHOSPHATASE; ANIMALS; BIOCOMPATIBLE MATERIALS; CELL SURVIVAL; CELLS, CULTURED; LACTIC ACID; MOLECULAR STRUCTURE; OSTEOBLASTS; POLYMERS; PROSTHESES AND IMPLANTS; RATS; RATS, SPRAGUE-DAWLEY; SKULL; SUBCUTANEOUS TISSUE;

EID: 0036379190     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.10298     Document Type: Article

References (28)

1. www.boneandjointdecade.org.
2. Lane JM, Tomin E, Bostrom PG. Biosynthetic bone grafting. Clin Orthop 1999;367:S107-S117.
3. Yasko AW, Lane JM, Fellinger EJ, Rosen V, Wozney JM, Wang EA. The healing of segmental defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). J Bone Joint Surg 1992:74A:659-670.
4. Urist MR. Bone morphogenetic protein: The molecularization of skeletal system development. J Bone Joint Surg 1997;12:343-346.
5. Centralla M, Horowitz MC, Wozney JM, McCarthy TL. Transforming growth factor-beta gene family members and bone. Endocr Rev 1994;15:27-29.
6. Beck LS, DeGuzman L, Wyne LP. TGF-beta 1 induces bone closure in skull defects. J Bone Miner Res 1991;6:1257-1265.
7. Goldstein SA. In vivo nonviral delivery factors to enhance bone repair. Clin Orthop 2000;379:S113-S119.
8. Fang J, Zhu Y, Smiley E, Bonadio J, Rouleau JP, Goldstein SA, McCauley LK, Davidson BL, Roessler BJ. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci USA 1996;93:5753-5758.
9. Connolly JF, Guse R, Tiedeman J, Dehne R. Autologous marrow injection as a substitute for operative grafting of tibial nonunions. Clin Orthop 1991;266:259-270.
10. Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. Characterization of cells with osteogenic potential from human marrow. Bone 1992;13:81-88.
11. Werntz JR. Qualitative and quantitative analysis of orthotopic bone regeneration by marrow. J Orthop Res 1996;14:85-93.
12. Behravesh E, Yasko AW, Engel PS, Mikos AG. Synthetic biodegradable polymers for orthopaedic applications. Clin Orthop 1999;367:S116-S125.
13. Burg KJ, Porter S, Kellam JF. Biomaterial developments for bone tissue engineering. Biomaterials 2000;21:2347-2359.
14. Holy CE, Shoichet MS, Davies JE. Engineering three-dimensional bone tissue in vitro using biodegradable scaffolds: Investigating initial cell-seeding density and culture period. J Biomed Mater Res 2000;51:376-382.
15. Ishaug SL, Crane GM, Miller MJ, Yasko AW, Yaszemski MJ, Mikos AG. Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res 1997;36:17-28.
16. Shea LD, Wang D, Franceschi RT, Mooney DJ. Engineered bone development from a pre-osteoblast cell line on three-dimensional scaffolds. Tissue Eng 2000;6:605-617.
17. Peter SJ, Kim P, Yasko AW, Yaszemski MJ, Mikos AG. Crosslinking characteristics of an injectable poly(propylene fumarate)/beta-tricalcium phosphate paste and mechanical properties of the crosslinked composite for use as a biodegradable bone cement. J Biomed Mater Res 1999;44:314-321.
18. Yaszemski MJ, Payne RG, Hayes WC, Langer R, Mikos AG. In vitro degradation of a poly(propylene fumarate)-based composite material. Biomaterials 1996;17:2127-2130.
19. Tangpasuthadol V, Pendharkar SM, Kohn J. Hydrolytic degradation of tyrosine-derived polycarbonates, a class of new biomaterials. Part I: Study of model compounds. Biomaterials 2000;21:2371-2378.
20. Burkoth AK, Anseth KS. A review of photocrosslinked polyanhydrides: In situ forming degradable networks. Biomaterials 2000;21:2395-2404.
21. Burkoth AK, Burdick J, Anseth KS. Surface and bulk modifications to photocrosslinked polyanhydrides to control degradation behavior. J Biomed Mater Res 2000;51:352-359.
22. Burdick JA, Philpott LM, Anseth KS. Synthesis and characterization of tetrafunctional lactic acid oligomers: a potential in situ forming degradable orthopaedic biomaterial. J Polym Sci Polym Chem 2001;39:683-692.
23. Burdick JA, Mason MN, Anseth KS. In situ forming lactic acid based orthopaedic biomaterials: influence of oligomer chemistry on osteoblast attachment and function. J Biomater Sci Polym 2001;12:1253-1265.
24. Agrawal CW, Ray RB. Biodegradable polymeric scaffolds for musculoskeletal tissue engineering. J Biomed Mater Res 2001;55:141-150.
25. Cook WD. Photopolymerization kinetics of dimethacrylates using the camphorquinone/amine initiator system. Polymer 1992;33:600-609.
26. Mikos AG, Thorsen AJ, Czerwonka LA, Bao Y, Langer R, Winslow DN, Vacanti JP. Preparation and characterization of poly(1-lactic acid) foams. Polymer 1994;35:1068-1077.
27. Ishaug SL, Yaszemski MJ, Bizios R, Mikos AG. Osteoblast function on synthetic biodegradable polymers. J Biomed Mater Res 1994;29:1445-1453.
28. Burkoth AK, Anseth KS. MALDI-TOF characterization of highly crosslinked, degradable polymer networks. Macromolecules 1999;32:1438-1444.